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Bullous morphea is a rare form of morphea characterized 
with bullae on or around atrophic morphea plaques. 
Whereas lichen sclerosus et atrophicus (LSA) is a disease the 
etiology of which is not fully known, and which is 
characterized with sclerosis. Coexistence of morphea and 
LSA has been identified in some cases. Some authors believe 
that these two diseases are different manifestations which are 
on the same spectrum. The 70-year-old patient stated herein, 
presented to us for 6 months with annular, atrophic plaques, 
ivory color in the middle, surrounded by living erythema, on 
the front and back of the trunk. Occasionally bulla formation 
on the plaques on the trunk lateral was identified. Fibrotic 
and atrophic plaques of ligneous hardness were present on 
the front side of tibia of both legs. In the histopathologic 
examination, the lesions were found concordant with 
bullous morphea and LSA. With colchicine 1.5 mg/day, 
pentoxifylline 1,200 mg/day, topical calcipotriol ointment 
and clobetasol propionate cream, the erythema in the 
patient's lesions faded and softening in the fibrotic plaques 
was observed. Concomitance of bullous morphea and LSA is 
a rarely seen, interesting coexistence which suggests a 
common, as yet unknown, underlying pathogenesis. (Ann 
Dermatol 23(S3) S354∼S359, 2011)
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INTRODUCTION
Bullous morphea is a rare form of morphea characterized 
with bullae on or around atrophic morphea plaques, as 
defined for the first time by Morrow in 1959
1. 
Lichen sclerosus (LS) is a chronic inflammatory skin di-
sease, which most commonly involves the anogenital 
region. The etiology of LS is obscure, but genetic sus-
ceptibility, autoimmune mechanisms, infective agents 
such as human papilloma virus and spirochaetes, as well 
as Koebner phenomenon have been postulated as cau-
sative factors
2.
Coexistence of morphea and lichen sclerosus et atro-
phicus (LSA) has been identified in some cases
2-11. Some 
authors believe that these two diseases are different cli-
nical manifestations on the same spectrum. Edema, paling, 
and collagen homogenization in the papillary dermis are 
more prominent in LSA; whereas the reticular dermis is 
also affected in morphea, and coarsening and parallel skin 
arrangement of collagen and atrophy in skin appendages 
is also evident. A 70-year-old male patient presented here-
with, whose simultaneously occurring lesions for 6 mon-
ths were found to be concordant with bullous morphea 
and LSA. Concomitance of bullous morphea and LSA is an 
interesting and rarely seen occurrence, and has a common 
and yet unexplained underlying pathogenesis. 
CASE REPORT
A 70-year-old male patient presented with complaints of 
wounds that were red around the edges, hard in the 
middle, and occasionally turned to blisters on the front A Case of Lichen Sclerosus et Atrophicus Accompanying Bullous Morphea
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Fig. 1. (A∼C) Circinate, atrophic pla-
ques surrounded by living erythe-
ma. Indurated plaques, whcih are 
bullous in the middle. (D) Fibrotic 
plaques on the anterior aspect and 
surface of the tibia.
and back of the trunk, ligneous hardening of the legs, and 
restriction and pain in knee joints for 6 months. He had 
occasionally applied topical creams to these aliments, but 
had not seen any benefit. He had a history of smoking 55 
packs/year for many years and loss of hearing in the left 
ear. No characteristics were identified in his family his-
tory. A system investigation and physical examination 
were within normal limits. The dermatological examina-
tion revealed: 
  * Circinate, atrophic plaques, surrounded by living 
erythema, yellow in the middle, ivory colored in places, 
in the form of a mane on both shoulders and in the 
mid-line on the back (Fig. 1A, B)
  * Indurated plaques on the abdomen, which were 
bullous in the middle (Fig. 1C)
  * Fibrotic plaques surrounded bilaterally with living 
erythema, which were hard in the middle, and  located on 
the anterior aspect or surface of the tibia (Fig. 1D).
The laboratory findings were positive C3 anti-HBs (hepatit 
B virus surface anticore) of 164 mg/dl (normal range, 79∼
152), positive (1:120 titer) antinuclear antibodies (ANAs) 
by indirect immunofluorescence (Hep-2 cells) (homogenous 
pattern), and negative anti-single-stranded DNA, anti 
double-stranded DNA, anti-SSA/Ro and Scl-70 but positive 
anti-SSB/La. Evaluations were made for the Lyme’s disease 
Ig M antibody (EIA) was negative, but the Lyme Ig G 
antibody (EIA) was positive at the detection limit (16 
RU/ml). 
Increased bilateral interstitial density was detected on 
pulmonary radiography; and moderate restrictive and ob-
structive combined type respiratory failure was observed 
on respiratory function tests. Thoracic computed tomo-
graphy (CT) revealed changes concordant with bullous 
and fibrotic tissue in subpleural areas, which were more 
prominent in the upper lobe apex of the right lung. 
Density changes were evident in the basal lower lobe of 
both lungs concordant with a chronic interstitial retention. 
High resolution CT was performed; however, no pathol-S Yasar, et al
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Fig. 2. (A, B) Epidermal atrophy and flattening of the rete ridges, vacuolar degeneration in the basal layer, edema in the papillary 
dermis (H&E, ×40, 100). (C, D) Subepidermal detachment in a focal area, coarsened collagen fibers (H&E, ×40, 100).
ogy was found. Ultrasonography  performed on the legs 
revealed that skin thickness had increased due to fibrosis. 
The histopathological examination performed on the atro-
phic follicular lesions on the upper back showed basket- 
weave hyperkeratosis in the epidermis, atrophy and flat-
tening of the rete ridges, vacuolar degeneration in the ba-
sal layer, edema in the papillary dermis, a pale appea-
rance, homogenization, melanine incontinence. Periva-
scular lymphocyte infiltration was observed on the skin 
appendages (Fig. 2A, B). These findings were believed to 
consistent with a histological diagnosis of LSA. Atrophy in 
the epidermis, deletion and flattening in the retes,  and 
subepidermal disintegration in the focal area were ob-
served on the biopsy performed on the atrophic area on 
which bulla had developed on  the abdomen. The papil-
lary dermis was severely edematous. Coarsening of col-
lagen fibers, the presence of a parallel to surface arran-
gement, and paling were observed in the mid and reti-
cular dermis. In most areas, skin appendages were re-
moved by coarse collagen fibers, whereas intensive 
lymphocyte infiltration was present in the reticular dermis 
(Fig. 2C, D). The findings were believed to be charac-
teristic of morphea. 
Additionally, we performed Masson’s trichrome and el-
astic Von Gieson staining  to evaluate the collagen and 
elastic fibers. Collagen bundles were sclerotic and coa-
rseness and elastic fibers were present within the scle-
rosing areas the areas with morphea. Collagen bundles 
were not sclerotic and the coarseness and elastic fibers 
decreased markedly in the dermis of areas with LSA (Fig. 
3, 4).
As a result, the patient was diagnosed with LSA and 
bullous morphea. An iommunofluorescence test and laser 
scanning confocal microscopy were not performed. 
Erythema of the lesions faded and the fibrotic plaques 
softened 6 weeks later after treatment with 1.5 mg/day 
colchicine, 1,200 mg/day pentoxifylline, topical calci-
potriol, and clobetasol propionate cream. As the patient A Case of Lichen Sclerosus et Atrophicus Accompanying Bullous Morphea
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Fig. 3. (A, B) Decrease of elastic 
fibers in lichen sclerosus et atro-
phicus  (elastic von Gieson, ×40,
100), (C, D) Normal limits of elastic 
fibers in morphea (elastic von Gie-
son, ×40, 100).
did not attend follow-up visits regularly, information could 
not be obtained on progress.
DISCUSSION
Bullous morphea is a rarely observed form of morphea. 
The bullous lesions are often localized to the lower 
abdominal area and lower extremities.
The bulla development mechanism in the sclerotic area is 
unclear. However, various hypotheses may explain bulla 
formation. Templeton claimed that bulla are caused by a 
lymphatic obstruction, and that the presence of enlarged 
lymphatic channels in the upper dermis supported this 
claim
2. Additionally, due to increased hydrostatic pres-
sure, bullous lesions are more frequently observed on the 
lower extremities. Other authors believe that bulla is 
caused by nerve damage from trauma, deposition of 
eosinophilic granule major basic protein, or enzymatic 
damage in the basal membrane caused by a vascular 
occlusion
3,12. However, in our case, the histopathological 
examination did not reveal increased eosinophils in tissue 
or serum or any vascular changes or lymphatic dilatation 
obstruction that would explain the pathogenesis. 
The correlation between spirochetes and bullous mor-
phea is disputable. In our case, evaluations were made for 
the Lyme Ig M antibody, which was negative, and the 
Lyme Ig G antibody, which was positive at the detection 
limit (16 RU/ml); however, the results did not suggest a 
Borrelia burgdorferi infection.
LSA is a chronic disease of the skin and mucosae, also 
known as kraurosis vulvae or balanitis xerotica obliterans
13. 
Despite being mostly localized to the anogenital region, it 
may also be localized on the upper parts of the back and 
chest area. Although B. burgdorferi, an autoimmune disor-
der, or trauma are major causes for this disease, the exact 
reason is unknown. Histopathologically distinguishing 
LSA from morphea in the extragenital region is difficult 
and sometimes even impossible. Lever stated that a classic 
LSA lesion shows hyperkeratosis with follicular plugging, 
atrophy of the Malpighian layer with vacuolar degene-
ration of the basal layer, edema. and homogenization of 
the collagen in the upper dermis, as well as an inflam-
matory infiltrate in the mid-dermis. However, all these 
findings are not always present, which makes interpre-
tation of the histological diagnosis more difficult
14. Our 
findings agreed with those of LSA, except for the follicular S Yasar, et al
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Fig. 4. (A∼C) In lichen sclerosus et
atrophicus, normal collagen fibers 
(Masson’s trichrome, ×40, 100, 200),
(D∼F) coarse, sclerosing collagen 
fibers in morphea (Masson’s tri-
chrome, ×40, 100, 200).
plugging. 
Borda et al. considered LSA as scleroderma of the papillary 
dermis and claimed that it could be a form of scleroderma. 
Uitto et al. also thought that histological findings of LSA 
and morphea could coexist in the same lesion, indicating 
that the two clinical lesions may, in some instances, 
represent a spectrum of disease rather than separate en-
tities
11. Connelly and Winkelmann argued that lichen 
slerosus and morphea are a spectrum of the same disease 
and that LSA is subepidermal morphea
15. Patterson and 
Ackerman believe that morphea and LSA are different 
clinical manifestations of the same disease spectrum. 
While changes in the papillary dermis are prominent in 
LSA, the reticular dermis is affected and concomitant 
systemic disease increases in patients with morphea
16. 
Several investigators have suggested additional histological 
techniques to distinguish between these two conditions 
when there is some uncertainty about the diagnosis. These 
include elastin staining (absent or greatly reduced in the 
upper dermis of LSA but not in morphea)
17,18 and 
differences in the dermal ground substance. Kowalewski et 
al. investigated alterations in the basement membrane 
zone (BMZ) and cutaneous microvasculature in patients 
with morphea and extragenital LSA using laser scanning 
confocal microscopy. They showed a decreased number 
and size of dermal papillae both in patients with morphea 
and LSA compared with those in normal skin. In patients 
with morphea, continuity of the BMZ at the level of 
lamina lucida, lamina densa and sublamina densa are 
preserved with numerous invaginations and holes in the 
BMZ at the level of the lamina lucida and lamina densa. 
They thought that alterations in the BMZ in patients with 
morphea differed from those in patients with LSA
19. 
The coexistence of morphea and LSA has been identified 
in some cases. It is unclear why bullous morphea and LSA 
coexist; however, both diseases have some common 
pathogenetic characteristics. The fact that spirochetes are 
involved in the etiologies of both diseases also supports a 
common pathogenesis. This close relationship raises the 
question of whether morphea and LSA are different 
indications of the same disease. Morphea and LSA have 
been associated with autoimmune diseases and auto-
antibodies of various types. Perhaps common autoim-
mune phenomena, a genetic predisposition, or a specific 
reaction to infection may play a role in patients with 
morphea-LSA. Anti-SSB/La and ANAs were detected in our 
patient, supporting the autoimmune hypothesis. Addi-
tionally, Dickie et al. provided direct evidence that LSA 
may have an immunological basis by showing positive 
immunofluorescent (IF) staining with fibrin, C3, or IgM in A Case of Lichen Sclerosus et Atrophicus Accompanying Bullous Morphea
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the basement membrane of lesional skin
20. But, we did 
not perform IF staining due to it unavailability in our 
hospital.
Coexistence of bullous morphea and LSA has been re-
ported in one case in the literature; however, that patient 
also had systemic lupus erythematosus
3. No underlying 
spirochete  infection was observed in our patient, nor any 
other autoimmune disease or history of trauma. The coexi-
stence may have been coincidental; however, common 
histopathological aspects such as intense edema and 
paling in the papillary dermis suggest the existence of the 
same disease in different developmental stages. We 
thought that the patient’s diagnosis was bullous morphea 
due to decreases in the normal limits of elastic fiber, 
sclerosing collagen, and diminished skin appendages but  
made the LSA diagnosis because of the decrease in elastic 
fibers and the absence of sclerosing collagen. 
Corticosteroids, antimalarial drugs, colchicine, retinoids, 
salazopyrin, pentoxifylline, UVA1 and wide band UVA 
are useful for treating bullous morphea. In our case, we 
achieved good results with 1.5 mg/day colchicine, 1,200 
mg/day pentoxifylline, topical calcipotriol ointment and 
clobetasol propionate cream.
The coexistence of bullous morphea and LSA is a rare 
condition and with an increase in the number of cases in 
the future, the question as to whether these two diseases 
are variants of the same disease will be clarified.
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